SynthesisMedical science monitor : international medical journal of experimental and clinical research2025
Role of Non-Coding RNAs in Pathogenesis, Diagnosis, and Therapy of Legg-Calvé-Perthes Disease: A Systematic Review.
Synthesis in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Legg-Calve-Perthes disease (LCPD) is sterile necrosis of the femoral head, being one of the most common such diseases in children. Non-coding RNAs have been implicated as new factors involved in it. These are transcripts without the potential to encode proteins, influencing gene expression, taking part in the development of diseases, and being both diagnostic markers and therapeutic targets. A systematic review of publications from 1993 to 2025 available in online databases was conducted, including 8 articles in the analysis. Non-coding RNAs play their role in the pathogenesis of LCPD by enhancing cell apoptosis, by inhibiting angiogenesis and promoting ischemia, and by enhancing inflammatory reactions mediated by reduced polarization of macrophages M2. Moreover, abnormalities in their expression levels in patients' serum appear to be good potential diagnostic markers of the disease. Some of them, such as miR-206, miR-214, and miR-223-5p, also have the potential to be used as therapeutic targets through beneficial effects on articular cartilage regeneration and improvement in blood supply. Further discovery of the role of non-coding RNAs in the pathogenesis of LCPD may contribute to a more complete understanding of it, as well as the development of new, effective diagnostic and therapeutic methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.